Revenue
2017
2018
2019
2020
2021
2022
2024
2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Price—Loading quote
Net income
2017
2018
2019
2020
2021
2022
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2022
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2024
2025
Financial statements
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.0M | $661.8M | $667.2M | $579.8M | $520.4M | $392.8M | $408.9M | $302.2M | $215.0M | $147.5M | $92.7M | $12.0M | $1.5M | $803,000 | $106,000 |
| Research & development | $106.2M | $108.8M | $74.6M | $90.5M | $76.0M | $69.1M | $89.2M | $49.6M | $42.8M | $29.1M | $19.6M | $17.2M | $23.5M | $30.6M | $35.1M |
| Operating income | −$62.3M | $81.7M | $46.1M | $86.0M | $173.7M | $148.6M | $144.4M | $99.5M | $54.2M | $20.8M | −$5.3M | −$61.9M | −$42.2M | −$37.8M | −$40.1M |
| EBITDAderived | $29.3M | $162.1M | $131.7M | $118.6M | $191.8M | $155.2M | $151.5M | $107.7M | $56.6M | $21.8M | −$4.3M | −$61.2M | −$41.3M | −$36.9M | −$38.9M |
| Net income | −$38.5M | $73.9M | $60.7M | $53.4M | $127.0M | $113.1M | $111.0M | $57.3M | $91.2M | $13.9M | −$10.9M | −$92.3M | −$46.3M | $53.8M | −$38.5M |
| Basic EPSper diluted share | -$0.68 | $1.34 | $1.13 | $1.01 | $2.41 | $2.16 | $2.13 | $1.13 | $1.84 | $0.29 | -$0.26 | -$2.90 | -$2.72 | $31.39 | -$26.38 |
| Diluted EPSper diluted share | -$0.68 | $1.32 | $1.04 | $0.98 | $2.36 | $2.10 | $2.05 | $1.08 | $1.76 | $0.28 | -$0.26 | -$2.90 | -$2.72 | $31.39 | -$26.38 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 18, 2026Form 4 · 10b5-1 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SellCommon Stock | 412 | $50.48 | $20.8K | 17.0K |
| Mar 18, 2026Form 4 · 10b5-1 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SellCommon Stock | 6.8K | $49.55 | $338.8K | 17.5K |
| Mar 17, 2026Form 4 · 10b5-1 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SellCommon Stock | 22.3K | $50.73 | $1.13M | 17.0K |
| Mar 17, 2026Form 4 · 10b5-1 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SellCommon Stock | 27.7K | $49.95 | $1.38M | 39.3K |
| Mar 16, 2026Form 4 · 10b5-1 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SellCommon Stock | 15.9K | $50.49 | $802.1K | 17.0K |